BHMT and chronic kidney disease: The accumulation of DMG will inhibit BHMT activity, thereby causing hyperhomocysteinemia, further leading to chronic renal failure (CRF).53 On the one hand, the active compounds in YGP may improve the activity of BHMT, and promote DMG to generate sarcosine.